Navigation Links
Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
Date:3/5/2013

IRVING, Texas, March 5, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, announced today that it has named Joachim Schorr , PhD, as its Chief Scientific Officer. He joins Caris in this role after working as a consultant with the company during the past year. In this expanded capacity, Dr. Schorr's extensive expertise in the molecular sciences arena will help to shape and advance Caris' research and development strategy.

"Having worked closely with Caris Life Sciences in 2012 as Senior Scientific Advisor, I have seen firsthand the world-class work being done every day at Caris to advance innovation in the field of personalized medicine," said Dr. Schorr. "Given our position as the emerging standard for cancer tumor profiling with the Molecular Intelligence Service, I am convinced that Caris is set to transform cancer diagnosis and patient care through its blood-based Carisome platform. I am excited to be part of this scientific paradigm shift."

Before joining Caris, Dr. Schorr held various leadership positions at QIAGEN N.V., the global leader in sample and assay Technologies, until April 2012. In his most recent role there, he served as Senior Vice President Global R&D and Managing Director, was a member of the Executive Committee and was responsible for research and development activities worldwide.  In addition to his expanded role as CSO for Caris, Dr. Schorr will continue to serve as a scientific consultant for QIAGEN.

During his 20-year career at QIAGEN, Dr. Schorr led the development of a global R&D function that created many new breakthrough products for use in life sciences research as well as molecular diagnostics. He also played a critical role in the successful integration of new technologies and products into the QIAGEN portfolio. In addition, he played key roles in the
'/>"/>

SOURCE Caris Life Sciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. TCS Named as a Leader in Life Science Drug Safety Services by Leading Industry Research Firm
2. Prime Therapeutics named a 2013 National Top Workplace
3. Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
4. Cohera Medical Named Winner of 2013 Carnegie Science Award
5. PharmaNet/i3 Renamed inVentiv Health Clinical
6. Randy Gaboriault of Christiana Care Health System Named Computerworld Premier 100 IT Leader
7. Heraeus Named "Supplier of the Year" by National Association of Dental Laboratories
8. AbbVie Named to S&P 500 Dividend Aristocrat Index
9. Roche Diagnostics Named to FORTUNE magazines 2013 list of "100 Best Companies to Work For"
10. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
11. Kareo Named a Top Workplace by the Orange County Register
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Germany , March 5, 2015 ... today announced that the foundation has made a ... CureVac, a leading clinical-stage biopharmaceutical company specializing in ... the foundation will also provide separate funding for ... CureVac,s proprietary messenger RNA (mRNA) platform. In addition, ...
(Date:3/5/2015)... , March 5, 2015  Sanomedics, Inc. (OTC: SIMH, ... company focused on developing, manufacturing, and acquiring cutting-edge technology, ... Thermomedics, Inc., will be exhibiting at booth # 709 ... Conference (NAPNAP) taking place on March 11-13, 2015 ... The 36 th ...
(Date:3/5/2015)... N.Y. , March 5, 2015  AMRI (NASDAQ: ... Pettersson , fills the newly created position of VP ... Christopher Conway , Senior Vice President of Global Sales ... Pettersson will lead the international sales team in an ... share in targeted market segments. Mr. Pettersson will drive ...
Breaking Medicine Technology:The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3AMRI Hires VP of International Sales 2
... , June 30 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services,Holdings Limited ("Concord ... network of radiotherapy and diagnostic imaging centers in China ,today announced ... , , ... the program, Concord Medical is authorized to repurchase up to US$20,million ...
... DIEGO , June 30 ADVENTRX Pharmaceuticals, Inc. (NYSE ... performed on samples of ANX-530 (vinorelbine injectable emulsion), or Exelbine™, manufactured ... are on track to support the submission of a New Drug ... , , ...
Cached Medicine Technology:Concord Medical Announces Share Repurchase Program 2Concord Medical Announces Share Repurchase Program 3ADVENTRX Announces 9-Month Stability Data Results for ANX-530 2ADVENTRX Announces 9-Month Stability Data Results for ANX-530 3
(Date:3/6/2015)... In a new study conducted at a ... that shoulder pain was their first mesothelioma symptom. Surviving Mesothelioma ... Click here to read it now. , Doctors at ... of 49 mesothelioma patients between 2006 and 2012 ... shoulder pain that first prompted them to see a doctor. ...
(Date:3/6/2015)... The Gluten-Free Certification Program (GFCP), ... pleased to announce that Dufflet Pastries, the ground-breaking ... their product line of gluten-free treats certified by ... as satisfying as any of their other desserts! ... contains hydrogenated fats or oils, artificial flavours, colours ...
(Date:3/6/2015)... FCPX developers have announced a new ... “Pro3rd Hue is a lower 3rd pack with a clean ... Studios. “Blurring the line between professional and armature, Pro3rd Hue ... set of 30 customizable lower third presets made exclusively for ... users can complement any design with a clean and simplistic ...
(Date:3/6/2015)... FL (PRWEB) March 06, 2015 The producers ... March 2015 air dates for Spokane, Washington and vicinity. This ... places to shop and dine, and many outdoor activities. It ... supporting the local economy. Six major hospitals call the city ... the Canadian border. The medically-focused cable TV program will be ...
(Date:3/6/2015)... 2015 Fluid Running® Owner, Jennifer Conroyd, ... the Fluid Running® method 3 years ago ... marathon. She hit upon the trifecta of combining matched-bpm ... a maximum-resistance, deep water running technique. She not only ... water running workout that made the experience both enjoyable ...
Breaking Medicine News(10 mins):Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3
... Most U.S. states are poorly prepared to deal with a ... in Japan, suggests a survey of state health departments. ... (76 percent) of state health departments responded to the [2010] ... plants." The findings were published online March 14 in ...
... 2011Since the first laparoscopic procedure was performed to remove ... in St. Louis, this breakthrough minimally invasive technique has ... remarkable achievement is celebrated with a series of cutting-edge ... journal published by Mary Ann Liebert, Inc. ( www.liebertpub.com ...
... Montreal, March 15, 2011 The Montreal Heart ... 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis ... coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, ... therapies to treat cardiovascular and metabolic diseases. ...
... University of the Negev (BGU) researchers have shown that a ... have Obstructive Sleep Apnea (OSA), which may be the reason ... compared men between the ages of 55 and 75 who ... and reported nocturia at least once nightly. The comparison control ...
... amount of data created by today,s high throughput DNA ... the globe. How to handle the staggering amount of ... questions that initiated the experiment? Aside from the cost ... are being spent worldwide to expand hardware and storage ...
... (BCS) results from hepatic venous outflow obstruction,at any ... Few patients respond to,medical treatment (anticoagulation thrombolytic ... restore the hepatic blood flow. Restoring outflow in ... dilatation stenting is the management of choice. ...
Cached Medicine News:Health News:U.S. Unprepared for Major Radiation Emergency: Survey 2Health News:20th anniversary of first laparoscopic nephrectomy 2Health News:Potential new treatment to reduce the burden of atherosclerosis in acute coronary syndrome patients 2Health News:mygenomatix: A secure cloud-like model for next-gen sequencing data analysis 2
Lyphochek Hemostasis Control is a multi-analyte control to help monitor coagulation factor assays and selected thrombosis risk assays. Assayed values are available for most major instrumentation....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
Medicine Products: